Big Win for Pfizer in Celebrex Litigation

Pharmalot has the details and the order (in Word form, with metadata indicating it originated from plaintiffs’ firm Lieff Cabraser) finding no Daubert-worthy evidence of causation at the most common dose of 200 mg.  You can also get the order in PDF form here: Download CelebrexDaubert.pdf.

See also the Reuters story.

–BC

(I have done some work in the Cox-2 litigation, but none in the Celebrex case and none of any sort for Pfizer.)